3912
S. Radomkit et al. / Tetrahedron 67 (2011) 3904e3914
1.88e2.01 (m, 2H), 2.05e2.17 (m, 2H), 2.49 (dd, 1H, J¼4.9, 8.1 Hz),
2.82 (dd, 1H, J¼2.2, 8.4 Hz), 3.82 (s, 3H), 4.73 (d, 1H, J¼4 Hz), 4.92 (d,
1H, J¼4.4 Hz), 4.95 (d, 1H, J¼8 Hz), 5.61e5.72 (m, 1H), 6.47 (s, 1H),
a 2.7:1 mixture of C2-C4 cis:trans diastereomers as colorless oil
(0.015 g, 0.034 mmol, 70%). Rf (30% EtOAc/hexanes) 0.54. IR (neat):
nmax 2960, 2228, 1608, 1574, 1486, 1443, 1399, 1311, 1261, 1197, 1159,
7.23 (s, 1H), 7.30e7.41 (m, 5H). 13C NMR (100 MHz, CDCl3):
d
29.3,
1052, 1020 cmꢀ1. 1H NMR (400 MHz, CDCl3):
d
0.54 (d, J¼7.0 Hz, 3H,
30.5, 30.8, 36.6, 56.1, 83.0, 100.7, 101.8, 115.0, 115.1, 126.9, 128.3,
128.6, 133.0, 137.9, 139.9, 154.7, 154.9. LRMS (EI) m/z (rel intensity)
374 (Mþþ1, 17), 372 (Mþꢀ1, 17), 241 (14), 239 (17), 217 (24), 215
(24), 178 (51), 161 (30), 149 (30), 117 (100), 91 (53), 71 (46), 69 (88).
TOF-HRMS calcd for C20H22BrO2 (MþHþ) 373.0798, found
373.0793.
minor), 0.58 (d, J¼6.6 Hz, 3H), 2.17e2.27 (m, 1H), 2.45e2.55 (m, 1H,
minor), 3.81 (d, J¼10.8 Hz, 1H), 3.813 (s, 3H), 3.86 (s, 3H, minor),
4.08 (d, J¼5.4 Hz, 1H, minor), 4.73 (d, J¼10.1 Hz, 1H), 4.75 (d,
J¼10.0 Hz, 1H, minor), 6.51 (s, 1H), 6.58 (s, 1H, minor), 6.69 (d,
J¼0.8 Hz, 1H), 7.05 (s, 1H, minor), 7.22e7.42 (m, 5H), 7.62 (AA0BB0,
J¼8.4 Hz, 2H), 7.64 (AA0BB0, J¼8.3 Hz, 2H). 13C NMR (100 MHz,
CDCl3):
d 15.2 (minor), 15.4, 36.8 (minor), 40.8, 45.8 (minor), 50.4,
4.1.22. 6-Bromo-7-methoxy-2,2-dimethyl-3-((S)-3-methyl pent-4-
enyl)chroman (40). Following the general procedure and purifica-
tion by PTLC (15% EtOAc/hexanes), the desired compound was
obtained as colorless oil (0.022 g, 0.062 mmol, 62%). Rf (15% EtOAc/
hexanes) 0.60. IR (neat): nmax 2931, 2865, 1610, 1577, 1486, 1497,
56.2, 79.3 (minor), 84.3, 100.7 (minor), 100.9, 102.7 (minor), 102.8,
110.8 (minor), 111.1, 116.7(minor), 118.4 (minor), 118.7, 125.5 (mi-
nor), 127.1 (minor), 127.4, 128.5, 128.6 (minor), 128.7, 128.8, 130.0,
130.8 (minor),131.9 (minor),132.6,133.3,133.6 (minor),138.8, 139.1
(minor), 147.2 (minor), 149.0, 154.8 (minor), 155.4, 155.5, 155.8
(minor). LRMS (EI) m/z (rel intensity) 435 (Mþþ2, 98), 433 (Mþ,
100), 344 (40), 342 (42), 317 (46), 316 (88), 315 (43), 314 (72), 263
(46), 118 (74), 117 (74). TOF-HRMS calcd for C24H21BrNO2 (MþHþ)
434.0750, found 434.0749.
1315, 1203, 1161, 1134, 1054 cmꢀ1. 1H NMR (400 MHz, CDCl3):
d 1.00
(d, 3H, J¼2.2 Hz), 1.02 (d, 3H, J¼2.2 Hz), 1.13 (s, 3H), 1.14 (s, 3H),
1.20e1.72 (m, 2H), 2.06e2.16 (m, 1H), 2.26e2.37 (m, 1H), 2.77 (td,
1H, J¼7.8, 2.5 Hz), 3.82 (s, 3H), 4.94 (d, 1H, J¼4.6 Hz), 4.97 (d, 1H,
J¼8.3 Hz), 5.60e5.75 (m, 1H), 6.36 (s, 1H), 7.18 (s, 1H). 13C NMR
(100 MHz, CDCl3):
d
19.9, 20.4, 20.5, 20.7, 27.1, 27.2, 27.5, 27.6, 28.2,
4.1.26. 6-Bromo-7-methoxy-3-methyl-2-phenyl-4-(4-(tri-
fluoromethoxy)phenyl) chroman (47). Following the general pro-
cedure and purification by PTLC (30% EtOAc/hexanes), the desired
compound was obtained as a 1.9:1 mixture of C2-C4 cis:trans di-
astereomers as colorless oil (0.010 g, 0.020 mmol, 51%). Rf (30%
EtOAc/hexanes) 0.62. IR (neat): nmax 2928, 1608, 1572, 1488, 1440,
28.3, 34.3, 34.5, 37.8, 37.9, 40.6, 41.0, 56.1, 78.2, 78.3, 101.2, 112.8,
113.1, 115.0, 132.9, 144.1, 144.5, 153.7, 154.9. LRMS (EI) m/z (rel in-
tensity) 354 (Mþþ2, 23), 352 (Mþ, 24), 217 (95), 215 (100). TOF-
HRMS calcd for C18H26BrO2 (MþHþ) 353.1111, found 353.1112.
4.1.23. 6-Bromo-7-methoxy-2-phenyl-4-(4-(trifluoromethoxy)phe-
nyl)chroman (44). Following the general procedure and purifica-
tion by PTLC (30% EtOAc/hexanes), the desired compound was
obtained as a 4:1 mixture of C2-C4 cis:trans diastereomers as col-
orless oil (0.019 g, 0.039 mmol, 83%). Rf (30% EtOAc/hexanes) 0.63.
1399, 1310, 1256, 1195, 1153, 1119, 1053, 1019 cmꢀ1
.
1H NMR
(200 MHz, CDCl3):
d
0.54 (d, J¼7.0 Hz, 3H, minor), 0.58 (d, J¼6.6 Hz,
3H), 2.16e2.26 (m,1H), 2.40e2.50 (m,1H, minor), 3.75 (d, J¼10.8 Hz
1H), 3.81 (s, 3H), 3.85 (s, 3H, minor), 4.03 (d, J¼5.2 Hz, 1H, minor),
4.73 (d, J¼10.1 Hz, 1H), 4.79 (d, J¼10.1 Hz, 1H, minor), 6.50 (s, 1H),
6.57 (s, 1H, minor), 6.77 (d, J¼0.9 Hz, 1H), 7.09e7.46 (m, 10H). 13C
1H NMR (400 MHz, CDCl3):
d
2.17 (ddd, J¼11.9, 11.8, 11.8 Hz, 1H),
2.38 (ddd, J¼13.8, 5.9, 1.8 Hz, 1H), 2.42e2.48 (m, 1H, minor), 3.85 (s,
3H), 3.89 (s, 3H, minor), 4.17 (dd, J¼5.5, 3.3 Hz, 1H, minor), 4.31 (dd,
J¼12.0, 5.8 Hz, 1H), 4.98 (dd, J¼10.5, 2.2 Hz, 1H, minor), 5.17 (dd,
J¼11.4, 1.5 Hz, 1H), 6.54 (s, 1H), 6.60 (s, 1H, minor), 6.89 (s, 1H), 7.12
(s, 1H, minor), 7.14e7.26 (m, 4H), 7.31e7.47 (m, 5H). 13C NMR
NMR (100 MHz, CDCl3): d 15.2 (minor), 15.4, 36.9 (minor), 40.9, 45.1
(minor), 49.6, 56.2, 79.3 (minor), 84.5, 100.6 (minor), 100.8, 102.6,
117.7 (minor), 119.3, 120.5 (minor), 121.1, 125.5 (minor), 127.2, 127.4,
128.4, 128.6 (minor), 128.7, 130.5, 131.3 (minor), 133.5, 133.7 (mi-
nor), 139.1, 140.3 (minor), 141.9, 154.8 (minor), 155.2, 155.5. LRMS
(EI) m/z (rel intensity) 494 (Mþþ2, 19), 492 (Mþ, 19), 191 (27), 289
(27), 278 (33), 277 (100), 117 (57), 91(26). TOF-HRMS calcd for
C24H21BrF3O3 (MþHþ) 493.0621, found 493.0618.
(100 MHz, CDCl3): d 40.5, 42.1, 56.2, 78.4, 101.1, 102.6, 113.6 (minor),
118.5, 121.0 (minor), 121.3, 126.0, 128.3, 128.57 (minor), 128.65,
129.6, 129.8 (minor), 133.1, 134.0 (minor), 140.3, 142.6, 148.1, 155.4,
155.7. TOF-HRMS calcd for C23H18BrF3O3 (Mþ) 478.0386, found
478.0379. These spectroscopic data were identical to those reported
previously.3a
4.1.27. 6-Bromo-7-methoxy-2-(4-methoxyphenyl)chroman
(53). Following the general procedure and purification by PTLC
(20% EtOAc/hexanes), the desired compound was obtained as col-
orless oil (0.032 g, 0.092 mmol, 99%). Rf (20% EtOAc/hexanes) 0.56.
IR (neat): nmax 3000, 2929, 2852, 1732, 1611, 1573, 1514, 1495, 1443,
1403, 1305, 1246, 1193, 1153, 1034 cmꢀ1. 1H NMR (200 MHz, CDCl3):
4.1. 24. 4-Allyl-6-bromo-7-methoxy-2-phenylchroman
(45). Following the general procedure and purification by PTLC
(15% EtOAc/hexanes), the desired compound was obtained as col-
orless oil (0.013 g, 0.033 mmol, 49%). Rf (15% EtOAc/hexanes) 0.52.
IR (neat): nmax 2916, 2853, 1609, 1568, 1488, 1443, 1199, 1156,
d
1.92e2.21 (m, 2H), 2.65e3.00 (m, 2H), 3.82 (s, 6H), 4.97 (dd, J¼9.6,
3.0 Hz, 1H), 6.48 (s, 1H), 6.93 (app. td, J¼8.8, 2.6 Hz, 2H), 7.24 (s, 1H),
1052 cmꢀ1
.
1H NMR (400 MHz, CDCl3):
d
1.98e2.14 (m, 1H),
7.34 (app. td, J¼8.8, 1.8 Hz, 2H). 13C NMR (50 MHz, CDCl3):
d 29.2,
2.17e2.29 (m, 2H), 2.27e2.44 (m, minor), 2.53e2.61 (m, minor),
2.68e2.475 (m, 1H), 2.80e2.88 (m, minor), 3.07e3.17 (m, 1H), 3.82
(s, 3H), 3.83 (s, minor), 4.98e5.15 (m, 3H), 5.71e5.90 (m, 1H), 6.49
(s, 1H), 6.51 (s, minor), 7.31e7.45 (m, 6H). 13C NMR (100 MHz,
29.5, 55.3, 56.2, 77.8, 101.3, 102.0, 114.0, 115.3, 127.4, 133.0, 133.5,
155.0,155.3,159.5. LRMS (EI) m/z (rel intensity) 351 (Mþþ3,14), 350
(Mþþ2, 78), 349 (MþHþ, 17), 348 (Mþ, 80), 271 (8), 269 (31), 134
(62), 121 (36), 91 (100). TOF-HRMS calcd for C17H18BrO3 (MþHþ)
349.0434, found 349.0435.
CDCl3):
d 32.8, 33.1, 33.8, 36.4, 38.8, 41.9, 73.9, 78.4, 101.1(minor),
101.3, 102.3, 117.4 (minor), 117.5, 118.8, 118.9 (minor), 125.9 (minor),
126.0, 128.0 (minor), 128.1, 128.6, 131.1, 133.1, 135.2, 135.9, 141.1,
154.9, 155.5. LRMS (EI) m/z (rel intensity) 360 (Mþþ2, 18), 358 (Mþ,
19), 319 (89), 317 (93), 238 (100), 223 (26), 115 (40), 104 (33), 91
(58). TOF-HRMS calcd for C19H20BrO2 (MþHþ) 359.0641, found
359.0650.
4.1.28. 2-(3-Benzyloxy-4-methoxy)phenyl-6-bromo-7-methoxychro-
man (54). Following the general procedure and purification by
PTLC (20% EtOAc/hexanes), the desired compound was obtained as
colorless oil (0.037 g, 0.082 mmol, 73%). Rf (20% EtOAc/hexanes)
0.44. 1H NMR (200 MHz, CDCl3):
d 1.92e2.21 (m, 2H), 2.64e2.76 (m,
1H), 2.82e3.04 (m, 1H), 3.86 (s, 3H), 3.93 (s, 3H), 4.96 (dd, J¼9.4,
4.1.25. 6-Bromo-7-methoxy-3-methyl-2-phenyl-4-(4-cyanophenyl)
chroman (46). Following the general procedure and purification by
PTLC (30% EtOAc/hexanes), the desired compound was obtained as
2.2 Hz, 1H), 5.20 (s, 2H), 6.50 (s, 1H), 6.92e7.03 (m, 3H), 7.29e7.50
(m, 6H). 13C NMR (50 MHz, CDCl3):
d
24.0, 29.4, 56.1, 56.2, 71.2, 77.8,
101.1, 101.9, 111.9, 112.4, 115.2, 119.1, 127.4, 127.8, 128.5, 133.0, 133.7,